Volunteer for Research : Vaccine Testing Center : University of Vermont

Department of Medicine

volunteer

Our team is actively recruiting for a number of clinical trials. Please contact us via the links below for more information.

Active - Recruiting
Study Title: A Phase 1 Evaluation of the Safety and Immunogenicity of the Recombinant Live Attenuated Tetravalent Dengue Vaccine
Purpose: The purpose of this study is to evaluate the safety, reactogenicity, and immunogenicity of a single formulation of the live attenuated tetravalent dengue vaccine when given as a subcutaneous injection to a person who has laboratory evidence or documented history of previous flavivirus infection.
ClinicalTrials.gov Identifier: NCT01506570
Primary/Site/Co Investigator: Beth Kirkpatrick, MD; Kristen Pierce, MD
Contact: Vaccine Testing Center
Information: clinicaltrials.gov

Active - Non-recruiting
Study Title: Evaluation of the Safety and Immune Response of Five Admixtures of a Tetravalent Dengue Virus Vaccine
Purpose: The goal of the Phase 1 vaccine trial is to determine the safety and immunogenicity of TetraVax-DV, a live attenuated tetravalent dengue vaccine candidate in healthy human subjects.
ClinicalTrials.gov Identifier: NCT01072786
Primary/Site/Co Investigator: Beth Kirkpatrick, MD; Kristen Pierce, MD
Contact: Vaccine Testing Center
Information: clinicaltrials.gov

Vaccine Testing Center
Department of Medicine

University of Vermont College of Medicine
95 Carrigan Drive
Burlington, VT 05405

Phone: (802) 656-0013
Fax: (802) 656-0881
Email: vaccinetestingcenter@uvm.edu

Questions about being a research volunteer? See Frequently Asked Questions.

Last modified April 18 2012 12:24 PM